Smaller, more frequent doses are often described as a way to keep AMPK signaling steadier, since the peptide has a short estimated half-life
Tumor-growth concern: Because IGF-1 signalling promotes cell proliferation, there is a theoretical concern it could promote growth of existing tumors
Inform your obstetrician of the specific medication (semaglutide or tirzepatide), your treatment duration, the maximum dose you reached, and when you stopped taking it
The arguments include the same dose range and same equipotent routes of application, regardless of the injury tested (Sikiric et al., 1993
This unprecedented tri-receptor synergy offers researchers a remarkably powerful, comprehensive tool to deeply study complex metabolic signaling interactions and systemic energy homeostasis
Unknown long-term effects: Generally speaking, most people seem to tolerate short-term use well, however, no one really knows the effects of using higher doses for the long-term